These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32867307)

  • 61. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antimycobacterial strategies to evade antimicrobial resistance in the nontuberculous mycobacteria.
    Millar BC; Moore JE
    Int J Mycobacteriol; 2019; 8(1):7-21. PubMed ID: 30860173
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
    Grzegorzewicz AE; Pham H; Gundi VA; Scherman MS; North EJ; Hess T; Jones V; Gruppo V; Born SE; Korduláková J; Chavadi SS; Morisseau C; Lenaerts AJ; Lee RE; McNeil MR; Jackson M
    Nat Chem Biol; 2012 Feb; 8(4):334-41. PubMed ID: 22344175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A review of current and promising nontuberculous mycobacteria antibiotics.
    Cantelli CR; Dassonville-Klimpt A; Sonnet P
    Future Med Chem; 2021 Aug; 13(16):1367-1395. PubMed ID: 34165325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait.
    Mokaddas E; Ahmad S
    Curr Microbiol; 2008 May; 56(5):413-7. PubMed ID: 18231831
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM; van Ingen J
    Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
    [No Abstract]   [Full Text] [Related]  

  • 71. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus.
    Malin JJ; Winter S; van Gumpel E; Plum G; Rybniker J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427298
    [No Abstract]   [Full Text] [Related]  

  • 72. Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.
    Negatu DA; Aragaw WW; Cangialosi J; Dartois V; Dick T
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0165522. PubMed ID: 36920191
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.
    Cândido PH; Nunes Lde S; Marques EA; Folescu TW; Coelho FS; de Moura VC; da Silva MG; Gomes KM; Lourenço MC; Aguiar FS; Chitolina F; Armstrong DT; Leão SC; Neves FP; Mello FC; Duarte RS
    J Clin Microbiol; 2014 Aug; 52(8):2990-7. PubMed ID: 24920766
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela.
    Da Mata-Jardín O; Angulo A; Rodríguez M; Fernández-Figueiras S; de Waard JH
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):433-441. PubMed ID: 31741101
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MmpL3 inhibitors as antituberculosis drugs.
    Shao M; McNeil M; Cook GM; Lu X
    Eur J Med Chem; 2020 Aug; 200():112390. PubMed ID: 32447196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720.
    Winthrop KL; Flume P; Hamed KA
    Expert Rev Anti Infect Ther; 2023; 21(11):1177-1187. PubMed ID: 37862563
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.
    Ford ES; Horne DJ; Shah JA; Wallis CK; Fang FC; Hawn TR
    Ann Am Thorac Soc; 2017 Jul; 14(7):1129-1138. PubMed ID: 28387523
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients.
    Gao J; Pei Y; Yan X; Shi G; Li T; Gao M; Liu Y; Wang Y; Shu W; Li L; Pang Y
    Int J Infect Dis; 2020 Nov; 100():196-198. PubMed ID: 32890726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discovery of benzothiazole amides as potent antimycobacterial agents.
    Graham J; Wong CE; Day J; McFaddin E; Ochsner U; Hoang T; Young CL; Ribble W; DeGroote MA; Jarvis T; Sun X
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3177-3181. PubMed ID: 30172617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.